CN111150880A - Antibacterial composite hydrogel and preparation method thereof - Google Patents
Antibacterial composite hydrogel and preparation method thereof Download PDFInfo
- Publication number
- CN111150880A CN111150880A CN202010017199.4A CN202010017199A CN111150880A CN 111150880 A CN111150880 A CN 111150880A CN 202010017199 A CN202010017199 A CN 202010017199A CN 111150880 A CN111150880 A CN 111150880A
- Authority
- CN
- China
- Prior art keywords
- solution
- hydrogel
- sodium alginate
- carboxymethyl chitosan
- mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 112
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 30
- 239000002131 composite material Substances 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title description 15
- 239000000243 solution Substances 0.000 claims abstract description 66
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 57
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 57
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 57
- 239000000661 sodium alginate Substances 0.000 claims abstract description 57
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 claims abstract description 49
- 239000001263 FEMA 3042 Substances 0.000 claims abstract description 49
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 claims abstract description 49
- 235000015523 tannic acid Nutrition 0.000 claims abstract description 49
- 229920002258 tannic acid Polymers 0.000 claims abstract description 49
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 claims abstract description 49
- 229940033123 tannic acid Drugs 0.000 claims abstract description 49
- 229920001661 Chitosan Polymers 0.000 claims abstract description 37
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 18
- 239000007853 buffer solution Substances 0.000 claims abstract description 17
- 238000002156 mixing Methods 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 13
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 239000002244 precipitate Substances 0.000 claims description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 238000000502 dialysis Methods 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 6
- 235000019441 ethanol Nutrition 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 239000011148 porous material Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 2
- 230000015556 catabolic process Effects 0.000 abstract description 7
- 238000006731 degradation reaction Methods 0.000 abstract description 7
- 239000002262 Schiff base Substances 0.000 abstract description 6
- 230000029663 wound healing Effects 0.000 abstract description 6
- 230000008569 process Effects 0.000 abstract description 4
- 230000004962 physiological condition Effects 0.000 abstract description 3
- 239000008055 phosphate buffer solution Substances 0.000 description 36
- 208000027418 Wounds and injury Diseases 0.000 description 15
- 206010052428 Wound Diseases 0.000 description 14
- 238000012360 testing method Methods 0.000 description 11
- 239000003814 drug Substances 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 230000005540 biological transmission Effects 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- 229920001864 tannin Polymers 0.000 description 5
- 239000001648 tannin Substances 0.000 description 5
- 235000018553 tannin Nutrition 0.000 description 5
- 150000004753 Schiff bases Chemical class 0.000 description 4
- 125000003172 aldehyde group Chemical group 0.000 description 4
- 230000003833 cell viability Effects 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000004599 antimicrobial Substances 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000002329 infrared spectrum Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 2
- 238000003828 vacuum filtration Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 208000034309 Bacterial disease carrier Diseases 0.000 description 1
- 102400000888 Cholecystokinin-8 Human genes 0.000 description 1
- 101800005151 Cholecystokinin-8 Proteins 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 241000195474 Sargassum Species 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 231100000334 hepatotoxic Toxicity 0.000 description 1
- 230000003082 hepatotoxic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 231100000512 nanotoxicity Toxicity 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001991 pathophysiological effect Effects 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- -1 polysaccharide carbohydrate Chemical class 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/009—Materials resorbable by the body
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Materials For Medical Uses (AREA)
Abstract
The invention relates to an antibacterial composite hydrogel which comprises the following components in percentage by mass and volume: 2-3.5% of carboxymethyl chitosan, 4-6% of oxidized sodium alginate and 0.3-0.6% of tannic acid, wherein the solution of the hydrogel is PBS buffer solution. The antibacterial composite hydrogel disclosed by the invention is prepared by mixing carboxymethyl chitosan, oxidized sodium alginate and tannic acid on the basis of carboxymethyl chitosan and oxidized sodium alginate under physiological conditions by using a dynamic Schiff base bond method, and has good degradation capability, biocompatibility, antibacterial property and mechanical property, and the wound healing process can be effectively promoted.
Description
Technical Field
The invention relates to an antibacterial composite hydrogel and a preparation method thereof, belonging to the technical field of medical biomaterials.
Background
Antibacterial wound dressings have gained increasing popularity in recent years, with most commercial suppliers now offering silvered or nanoparticle impregnated dressings. Although such dressings have a broad spectrum of antimicrobial efficacy, several studies have also reported that silver is cytotoxic to mammalian cells and negatively affects the wound healing process. In addition, silver wound dressings are expensive and there continues to be concern about nanoparticle absorption and nanotoxicity. Accordingly, there has been considerable effort directed to identifying alternative antimicrobial agents.
Tannic Acid (TA) is an antioxidant, antimicrobial, antiviral and anti-inflammatory agent and is used as the first treatment of clinical burn injuries in the mid-20 th century. This treatment was abandoned in the 40 s due to concerns about hepatotoxic effects. However, recent re-assessment of earlier studies indicates that natural pathophysiological phenomena are the cause, not TA poisoning. Thus, the use of TA as an adjunct to burn wounds and other therapeutic applications, including as an antimicrobial agent, has been renewed. Given the recent reevaluation of TA toxicity, and the results demonstrating biocompatibility, the local application of TA may be subject to less stringent regulatory conditions in the future. There are studies that demonstrate TA by relying on the putative staphylococcal antigen a, transglycosylase. Biocompatible and biodegradable TA hydrogels with antibacterial and antioxidant properties have recently been reported, synthesizing TA/chitosan/pullulan composite nanofibers for wound healing, although these materials are not pH sensitive. However, the development of pH sensitive hydrogels for TA controlled release has not been reported.
Severely exuding wounds require regular dressing changes to limit bacterial colonization and induce wound healing. The balance between exudate absorption and moisture release can be adjusted using hydrogels, with superabsorbent gels being the most preferred. Among the different hydrogels, responsive hydrogels are of great interest due to their potential to react to external triggers (e.g., pH) and release their payload in a more controlled manner. Among them, the Schiff base crosslinked hydrogel is an ideal pH-responsive hydrogel. Wound fluid pH plays a crucial role in the wound healing process. Although the pH of intact skin is 5.5, the pH of the wound environment can vary significantly depending on the type of wound, the stage of the healing process, or other factors (e.g., infection). The pH of the stage I pressure ulcer is about 5.5-5.6, which will allow it to be treated with a wound dressing. The crosslinking mechanism of the Schiff base crosslinked hydrogel is as follows: the amino and aldehyde group react under neutral or alkaline conditions to generate C ═ N double bonds, and the generated C ═ N double bonds are easily decomposed under acidic conditions, so that the mechanism can provide good conditions for the release of the wound dressing drug.
Carboxymethyl chitosan is a chitosan derivative having biodegradability, biocompatibility and inherent antibacterial activity, and is one of hot spots in research of antibacterial agents. The antibacterial mechanism of carboxymethyl chitosan is that under the condition that the pH value is lower than 6, the positive charge of amino at the C-2 position can interact with the surface of bacteria, so that the bacteria die. Sodium Alginate (SA) is a polysaccharide carbohydrate extracted from brown algae such as herba Zosterae Marinae or Sargassum, and has good biodegradability and biocompatibility. The sodium alginate is easy to dissolve in water, and has good gelatinization performance, strong hygroscopicity and good water retention performance.
The invention adopts a dynamic Schiff base method to prepare the biocompatible hydrogel wound dressing with inherent antibacterial activity. Under physiological conditions, a tannic acid/oxidized sodium alginate (TA/OSA) solution is mixed with a carboxymethyl chitosan (CMC) solution to prepare the hydrogel. In the invention, the antibacterial performance of the OSA-CMC hydrogel is improved by adding the tannic acid.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provide the antibacterial composite hydrogel and the preparation method thereof, and the hydrogel has excellent biocompatibility and antibacterial performance.
In order to achieve the purpose, the invention adopts the technical scheme that: an antibacterial composite hydrogel comprises the following components in percentage by mass and volume: 2-3.5% of carboxymethyl chitosan, 4-6% of oxidized sodium alginate and 0.3-0.6% of tannic acid, wherein the solution of the hydrogel is PBS buffer solution.
As a preferred embodiment of the hydrogel, the hydrogel comprises the following components in percentage by mass and volume: 3% of carboxymethyl chitosan, 5% of oxidized sodium alginate, 0.5% of tannic acid and the solution of the hydrogel is PBS buffer solution.
As a preferred embodiment of the hydrogel of the present invention, the preparation method of oxidized sodium alginate comprises: dissolving sodium alginate in ethanol, heating in water bath, slowly dropwise adding sodium periodate aqueous solution into sodium alginate solution after sodium alginate is completely dissolved, and stirring for reaction; after the reaction is finished, dropwise adding ethylene glycol, continuously stirring, then adding sodium chloride, pouring the reaction solution into absolute ethyl alcohol, and separating out a precipitate; vacuum filtering, dissolving the precipitate with pure water, dialyzing, and freeze drying to obtain oxidized sodium alginate.
As a preferred embodiment of the hydrogel, the mass ratio of the sodium alginate to the sodium periodate is 1: 1.
As a preferred embodiment of the hydrogel, the temperature of the water bath heating is 60 ℃, the stirring reaction time is 5h, the continuous stirring time is 1h, the cut-off molecular weight of the dialysis bag for dialysis is 8000-15000, and the freeze drying temperature is-80 ℃.
As a preferred embodiment of the hydrogel of the present invention, the preparation method of oxidized sodium alginate comprises: dissolving 10g of sodium alginate in 250mL of 15% (v/v) ethanol solution to prepare 4% w/v solution, heating the solution in a water bath to 60 ℃, weighing 10g of sodium periodate after the sodium alginate is completely dissolved, dissolving the sodium periodate in 20mL of pure water, slowly dropwise adding the solution into the sodium alginate solution under the conditions of light protection and rapid stirring, and reacting for 5 hours; after the reaction is finished, 2mL of ethylene glycol is dropwise added into the reaction solution, and stirring is continued for 1 h; adding 10g of sodium chloride, pouring the reaction solution into 500mL of absolute ethyl alcohol, separating out a precipitate, carrying out vacuum filtration, dissolving the precipitate again by using 50mL of pure water, and dialyzing the precipitate for three days by using a dialysis bag with the molecular weight cutoff of 8000-15000; after dialysis, the solution is freeze-dried at-80 ℃ to obtain oxidized sodium alginate solid.
In a second aspect, the present invention provides a method for preparing the above hydrogel, comprising the steps of:
(1) dissolving carboxymethyl chitosan in a PBS buffer solution to form a solution A;
(2) dissolving oxidized sodium alginate and tannic acid in a PBS buffer solution to form a solution B;
(3) and (3) mixing the solution A obtained in the step (1) and the solution B obtained in the step (2), then placing the mixture in a 48-hole cell pore plate, and uniformly stirring to obtain the antibacterial composite hydrogel.
As a preferred embodiment of the method for producing a hydrogel according to the present invention, the volume ratio of the solution a to the solution B is 1: 1.
in a preferred embodiment of the method for preparing the hydrogel according to the present invention, the carboxymethyl chitosan is present in the solution a in an amount of 4 to 7% by mass/volume. Preferably, the mass volume percentage of the carboxymethyl chitosan is 6%.
As a preferable embodiment of the preparation method of the hydrogel, in the solution B, the mass volume percentage of the oxidized sodium alginate is 8% to 12%. Preferably, the mass volume percentage of the oxidized sodium alginate is 10%.
As a preferable embodiment of the method for producing the hydrogel according to the present invention, the mass volume percentage of tannic acid in the solution B is 0.6% to 1.2%. Preferably, the mass volume percentage of tannic acid is 1%.
Compared with the prior art, the invention has the beneficial effects that:
(1) the antibacterial composite hydrogel disclosed by the invention is prepared by mixing carboxymethyl chitosan, oxidized sodium alginate and tannic acid on the basis of carboxymethyl chitosan and oxidized sodium alginate under physiological conditions by using a dynamic Schiff base bond method, and has good degradation capability, biocompatibility, antibacterial property and mechanical property, and the wound healing process can be effectively promoted.
(2) Compared with the in vitro and in vivo antibacterial hydrogel reported in the past, the hydrogel disclosed by the invention has excellent biocompatibility and antibacterial performance; the hydrogel disclosed by the invention can be slowly degraded under the environment condition of a wound to release tannic acid, so that an antibacterial effect is achieved, and meanwhile, the carboxymethyl chitosan in the hydrogel also has a certain antibacterial property, so that the bacterial number and the inflammation level of the wound can be effectively reduced.
Drawings
FIG. 1 is a graph showing the solubility of chitosan and carboxymethyl chitosan.
FIG. 2 is a scanning electron microscope photograph of the hydrogel prepared in example 1.
FIG. 3 is an infrared spectrum of sodium alginate and oxidized sodium alginate.
FIG. 4 is a graph showing swelling ratios of the hydrogels prepared in examples 1 and 5.
FIG. 5 is a graph showing the degradation performance test of the hydrogel prepared in example 1.
FIG. 6 is a statistical chart of the compressive strength of the hydrogels prepared in examples 1-5.
FIG. 7 is a statistical chart of the water vapor transmission rate of the hydrogels prepared in examples 1-5.
FIG. 8 is a graph showing the water vapor drug release results of the hydrogel prepared in example 5.
FIG. 9 is a statistical graph of cell viability of the hydrogels prepared in example 1 and example 5.
Detailed Description
To better illustrate the objects, aspects and advantages of the present invention, the present invention will be further described with reference to the accompanying drawings and specific embodiments.
Example 1
An OSA/6% CMC hydrogel comprises the following components in percentage by mass and volume: 3% of carboxymethyl chitosan (CMC) and 5% of Oxidized Sodium Alginate (OSA), wherein the solution of the hydrogel is PBS buffer solution.
The preparation method comprises the following steps: 0.2mL of CMC (6% w/v in PBS) and 0.2mL of OSA (10% w/v in PBS) were placed in a 48-well cell-well plate, and the mixture was gently stirred using a gun head to obtain an OSA/6% CMC hydrogel.
The preparation method of the oxidized sodium alginate comprises the following steps: dissolving 10g of sodium alginate in 250mL of 15% (v/v) ethanol solution to prepare 4% w/v solution, heating the solution in a water bath to 60 ℃, weighing 10g of sodium periodate after the sodium alginate is completely dissolved, dissolving the sodium periodate in 20mL of pure water, slowly dropwise adding the solution into the sodium alginate solution under the conditions of light protection and rapid stirring, and reacting for 5 hours; after the reaction is finished, 2mL of ethylene glycol is dropwise added into the reaction solution, and stirring is continued for 1 h; adding 10g of sodium chloride, pouring the reaction solution into 500mL of absolute ethyl alcohol, separating out a precipitate, carrying out vacuum filtration, dissolving the precipitate again by using 50mL of pure water, and dialyzing the precipitate for three days by using a dialysis bag with the molecular weight cutoff of 8000-15000; after dialysis, the solution is freeze-dried at-80 ℃ to obtain oxidized sodium alginate solid.
Example 2
An OSA/4% CMC hydrogel comprises the following components in percentage by mass and volume: 2% of carboxymethyl chitosan (CMC) and 5% of Oxidized Sodium Alginate (OSA), wherein the solution of the hydrogel is PBS buffer solution.
The preparation method comprises the following steps: 0.2mL of CMC (4% w/v in PBS) and 0.2mL of OSA (10% w/v in PBS) were placed in a 48-well cell-well plate, and the mixture was gently stirred using a gun head to obtain an OSA/4% CMC hydrogel.
Example 3
An OSA/5% CMC hydrogel comprises the following components in percentage by mass and volume: 2.5% of carboxymethyl chitosan (CMC) and 5% of Oxidized Sodium Alginate (OSA), wherein the solution of the hydrogel is PBS buffer solution.
The preparation method comprises the following steps: 0.2mL of CMC (5% w/v in PBS) and 0.2mL of OSA (10% w/v in PBS) were placed in a 48-well cell-well plate, and the mixture was gently stirred using a gun head to obtain an OSA/5% CMC hydrogel.
Example 4
An OSA/7% CMC hydrogel comprises the following components in percentage by mass and volume: 3.5% of carboxymethyl chitosan (CMC) and 5% of Oxidized Sodium Alginate (OSA), wherein the solution of the hydrogel is PBS buffer solution.
The preparation method comprises the following steps: 0.2mL of CMC (7% w/v in PBS) and 0.2mL of OSA (10% w/v in PBS) were placed in a 48-well cell-well plate, and the mixture was gently stirred using a gun tip to obtain an OSA/7% CMC hydrogel.
Example 5
An OSA/6% CMC/TA composite hydrogel comprises the following components in percentage by mass and volume: 3% of carboxymethyl chitosan, 5% of oxidized sodium alginate and 0.5% of Tannic Acid (TA), wherein the solution of the hydrogel is PBS buffer solution.
The preparation method comprises the following steps: 0.2mL of CMC (6% w/v in PBS) and 0.2mL of OSA/TA (10% w/v OSA and 1% w/v TA in PBS) were placed in a 48-well cell-well plate, and the mixture was gently stirred using a lance tip to obtain an OSA/6% CMC/TA composite hydrogel.
Example 6
An OSA/CMC/TA composite hydrogel comprises the following components in percentage by mass and volume: 2% of carboxymethyl chitosan, 4% of oxidized sodium alginate and 0.3% of Tannic Acid (TA), wherein the solution of the hydrogel is PBS buffer solution.
The preparation method comprises the following steps: 0.2mL of CMC (4% w/v in PBS) and 0.2mL of OSA/TA (8% w/v OSA and 0.6% w/v TA in PBS) were placed in a 48-well cell-well plate, and the mixture was gently stirred using a lance tip to obtain an OSA/CMC/TA composite hydrogel.
Example 7
An OSA/CMC/TA composite hydrogel comprises the following components in percentage by mass and volume: 3.5% of carboxymethyl chitosan, 6% of oxidized sodium alginate and 0.6% of Tannic Acid (TA), wherein the solution of the hydrogel is PBS buffer solution.
The preparation method comprises the following steps: 0.2mL of CMC (7% w/v in PBS) and 0.2mL of OSA/TA (12% w/v OSA and 1.2% w/v TA in PBS) were placed in a 48-well cell-well plate, and the mixture was gently stirred using a lance tip to obtain an OSA/CMC/TA composite hydrogel.
Examples of effects
(1) Solubility of carboxymethyl chitosan
0.02g of chitosan is dissolved in neutral water, and 0.02g of carboxymethyl chitosan is dissolved in neutral water. The clarity of the solution was observed and the results of the dissolution are shown in figure 1.
The results show that the water solubility of chitosan in neutral water is turbid, and the sample is insoluble. The carboxymethyl chitosan has good solubility in neutral water, because the carboxyl in the carboxymethyl chitosan obviously improves the solubility of the chitosan.
(2) Scanning electron microscopy
The OSA/6% CMC hydrogel prepared in example 1 was placed in liquid nitrogen, after it had set, it was gently broken with a glass rod, a suitable cross-section was selected, lyophilized, and the appearance of the lyophilized sample was photographed with a scanning electron microscope, the scanning electron microscope image of which is shown in fig. 2.
As can be seen from FIG. 2, the hydrogel has a better pore size, and is suitable for entrapping and releasing tannic acid.
(3) Infrared spectrogram
Preparing a sample to be detected by a potassium bromide tabletting method, and measuring the infrared spectrum by using a Fourier infrared spectrometer. FIG. 3 is an infrared spectrum of Sodium Alginate (SA) and Oxidized Sodium Alginate (OSA), wherein the molecular structure of Sodium Alginate (SA) has more hydroxyl groups, and the hydroxyl groups are mutually influenced to make it be 3410cm-1Shows a broad peak, and after partial hydroxyl groups are oxidized by sodium periodate, the peak is at 3410cm-1The absorption peak is weakened, because the molecular structure of the sodium alginate has carboxyl, the absorption peak of the aldehyde group after the sodium periodate oxidation coincides with the carboxyl, but is 1150cm-1And a new absorption peak appears, which is the absorption peak of the C-O bond in the aldehyde group, and can prove that part of hydroxyl in the sodium alginate is oxidized into the aldehyde group.
(4) Swelling Rate test
The weight of the hydrogel was weighed using balance and recorded as W0The hydrogel was placed in PBS (0.01M, pH 7.4) and at a specific time point, the surface of the hydrogel was quickly wiped off with a slightly moistened filter paper (moist atraumatic gel), and weighed and reported as Ws. Each sample was run in parallel for three times and averaged, and the swelling ratio of the sample was calculated as follows:
wherein, W0Weight of hydrogel (g); wsWeight (g) of hydrogel after water absorption; x is the swelling ratio (%) of the hydrogel.
FIG. 4 is a graph showing the swelling ratios of the samples of example 1(OSA/CMC) and example 5(OSA/CMC/TA) which are not very different from each other, and the swelling ratio of the hydrogel loaded with tannic acid is slightly reduced compared with that of the pure water gel.
(5) Test for degradation Properties
Get water to be condensedThe mass of the gum after it has been released from the mould is designated W0Then, the mixture was immersed in a PBS solution at pH 7.4 and pH 5.5 and placed on a constant temperature shaker (37 ℃ C., 70 rpm). At the time points of measurement (1, 3, 7, 14, 21 days), the hydrogel was removed, the surface of the hydrogel was quickly wiped off with slightly wetted filter paper, and the mass was accurately weighed and recorded (W)1). Calculating the weight ratio after degradation by adopting a formula: weight after degradation is W1/W0*100%
Fig. 5 is a graph showing the degradation performance of example 1 in PBS buffer solution with PH 7.4 and PH 5.5, and it can be found that the hydrogel degrades in the solution with PH 5.5 significantly faster than in the solution with PH 7.4, because the hydrogel is a schiff base crosslinked hydrogel, and the C ═ N double bond is unstable and easily dissociates under acidic conditions.
(6) Compression modulus test
The diameter and length of the hydrogel were measured using a vernier caliper, and the compression modulus of elasticity of the sample was tested using an electronic universal tester at a deformation rate of 1mm/min within 40% deformation.
FIG. 6 shows the results of the compressive strength tests of examples 1 to 5, from which it can be seen that the compressive strength of the hydrogel is the greatest when the OSA concentration is constant and the final concentration of CMC is 3%; pure hydrogel has a compression strength comparable to that of hydrogel loaded with tannic acid.
(7) Water vapor transmission rate test
The Water Vapor Transmission Rate (WVTR) of the hydrogel was determined according to ASTM E96-00 by the United states Bureau of standards. The method comprises the following specific steps: first, the hydrogel was placed at the mouth of a vial (diameter 9.67mm) already filled with 5mL of deionized water, the gap between the hydrogel and the mouth was sealed with vaseline to prevent water vapor from escaping, and the initial weight was weighed. Next, the hydrogel-covered sample bottle was placed in a constant temperature and humidity incubator (temperature 37 ℃, relative humidity 79%), and a sample bottle containing only 5mL of deionized water was used as a blank control group. After 24h, the mixture was taken out and weighed. The water vapor transmission rate is calculated according to the following formula:
wherein, Deltam/Deltat is the water loss weight loss (g/day) of 24 hours, and A is the surface area (m) of the bottle mouth2)。
Fig. 7 shows the water vapor transmission rate test results of examples 1 to 5, and it can be seen from the figure that examples 1 to 5 all have good water vapor transmission rate, good water and air permeable functions, and can maintain a high humidity environment for the wound surface to promote its rapid healing.
(8) Hydrogel in vitro drug release test
Adding the prepared drug-loaded composite hydrogel into 10mL of PBS solution, placing the solution in a constant-temperature shaking table at 37 ℃, taking out 1mL of aqueous solution at a specific time point, adding 1mL of new PBS to keep the volume of the 10mL of PBS solution unchanged, measuring the concentration of the drug in the taken-out solution by using an ultraviolet spectrophotometer, and continuously measuring the release behavior of the drug-loaded hydrogel for 7 days.
Fig. 8 is a graph of the results of example 5 drug release in PBS solution at PH 7.4 and PH 5.5, from which it can be seen that the drug released most of the tannins on the first day and then slowly released over a subsequent period. In a PBS (phosphate buffer solution) with the pH value of 5.5, tannin is released more quickly than the PBS with the pH value of 7.4, the final release amount is more than the PBS with the pH value of 7.4, and the pH environment of a wound is acidic.
(9) Biocompatibility testing
Cultured L929 cells were digested with 0.25% trypsin and suspended at a density of 2X 10 per well4one/mL cell suspension was seeded in 48-well plates. After 12h of culture, the original culture solution was taken out, and 500. mu.L of the leaching solution of the experimental material was added to each well dish, and only 500. mu.L of complete medium was added as a blank control. Each group is provided with at least 5 holes. Liquid is changed every 24h, and two time points of 24h and 48h are set in the experiment. The specific operation method comprises the following steps:
cell survival rate: cell viability was quantified using CCK 8. Taking out corresponding holes at specified time intervalsPlate, 100. mu.L of CCK8 working solution per well, carbon dioxide incubator (containing 5% CO) at constant temperature of 37 deg.C2) After incubation for 1-2 h, measuring absorbance (OD) at the wavelength of 450nm by using an enzyme-labeling instrument, and calculating the cell survival rate according to a formula:
cell survival (%) ═ ODShort experiment/ODContrast medium×100%。
FIG. 9 is a statistical graph of cell viability for examples 1 and 5, and it can be seen that the cell viability of tannin-loaded hydrogels was slightly decreased compared to that of pure hydrogel, but both survivors were over 80%, which confirms that both hydrogel materials and tannin-loaded composite hydrogels have better biocompatibility and can be used for treating skin wounds.
(10) Zone of inhibition test
A round sample of the prepared hydrogel (diameter 8mm) was sterilized by UV irradiation on a clean bench for 30 min. Dripping 100 μ L of the bacterial suspension on a solid LB culture medium, uniformly coating and sticking a sample to be detected on a coating rod, rightly placing for 15min, and placing the culture dish in a 37 ℃ biochemical incubator for inverted culture. After 24h of culture, the growth of bacteria on the culture medium was observed, the diameter (D) of the zone of inhibition was recorded, and the hydrogel prepared in examples 1 to 7 was subjected to zone of inhibition tests, the test results being shown in Table 1.
TABLE 1
As can be seen from the table 1, the hydrogel has a certain antibacterial effect, the concentration of the OSA is controlled to be unchanged, the antibacterial effect of the CMC is enhanced along with the increase of the concentration within the concentration range of 2-3%, and when the final concentration of the CMC is increased to 3.5%, the antibacterial effect is not great as that of 3%; after the tannin is loaded, the antibacterial effect of the hydrogel is obviously enhanced. The antibacterial effect of example 5 is the best, and the hydrogel comprises the following components in percentage by mass and volume: the best antibacterial effect is achieved when the content of the carboxymethyl chitosan is 3%, the content of the oxidized sodium alginate is 5%, and the content of the tannic acid is 0.5%.
Finally, it should be noted that the above embodiments are only used for illustrating the technical solutions of the present invention and not for limiting the protection scope of the present invention, and although the present invention is described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications or equivalent substitutions can be made on the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention.
Claims (10)
1. An antibacterial composite hydrogel is characterized by comprising the following components in percentage by mass and volume: 2-3.5% of carboxymethyl chitosan, 4-6% of oxidized sodium alginate and 0.3-0.6% of tannic acid, wherein the solution of the hydrogel is PBS buffer solution.
2. The hydrogel according to claim 1, comprising the following components in mass volume percent: 3% of carboxymethyl chitosan, 5% of oxidized sodium alginate, 0.5% of tannic acid and the solution of the hydrogel is PBS buffer solution.
3. The hydrogel according to claim 1 or 2, wherein the oxidized sodium alginate is prepared by a method comprising: dissolving sodium alginate in ethanol, heating in water bath, slowly dropwise adding sodium periodate aqueous solution into sodium alginate solution after sodium alginate is completely dissolved, and stirring for reaction; after the reaction is finished, dropwise adding ethylene glycol, continuously stirring, then adding sodium chloride, pouring the reaction solution into absolute ethyl alcohol, and separating out a precipitate; vacuum filtering, dissolving the precipitate with pure water, dialyzing, and freeze drying to obtain oxidized sodium alginate.
4. The hydrogel according to claim 3, wherein the mass ratio of sodium alginate to sodium periodate is 1: 1.
5. The hydrogel according to claim 3, wherein the temperature of the water bath heating is 60 ℃, the time of the stirring reaction is 5 hours, the time of the continuous stirring is 1 hour, the cut-off molecular weight of the dialysis bag for dialysis is 8000-15000, and the temperature of the freeze-drying is-80 ℃.
6. A method of preparing a hydrogel according to any one of claims 1 to 5 comprising the steps of:
(1) dissolving carboxymethyl chitosan in a PBS buffer solution to form a solution A;
(2) dissolving oxidized sodium alginate and tannic acid in a PBS buffer solution to form a solution B;
(3) and (3) mixing the solution A obtained in the step (1) and the solution B obtained in the step (2), then placing the mixture in a 48-hole cell pore plate, and uniformly stirring to obtain the antibacterial composite hydrogel.
7. The method of claim 6, wherein the volume ratio of solution A to solution B is 1: 1.
8. the method for preparing a hydrogel according to claim 6, wherein the carboxymethyl chitosan is present in the solution A in an amount of 4 to 7% by mass.
9. The method for preparing hydrogel according to claim 6, wherein the mass volume percentage of oxidized sodium alginate in the solution B is 8-12%.
10. The method of preparing a hydrogel according to claim 6, wherein the mass volume percentage of tannic acid in the solution B is 0.6 to 1.2%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010017199.4A CN111150880A (en) | 2020-01-08 | 2020-01-08 | Antibacterial composite hydrogel and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010017199.4A CN111150880A (en) | 2020-01-08 | 2020-01-08 | Antibacterial composite hydrogel and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111150880A true CN111150880A (en) | 2020-05-15 |
Family
ID=70561972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010017199.4A Pending CN111150880A (en) | 2020-01-08 | 2020-01-08 | Antibacterial composite hydrogel and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111150880A (en) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111793224A (en) * | 2020-06-28 | 2020-10-20 | 武汉科技大学 | Preparation method and application of biomimetic fibrous mesh hydrogel with self-healing properties |
CN111905152A (en) * | 2020-07-06 | 2020-11-10 | 中国科学院上海硅酸盐研究所 | Silicon-based bioactive glass composite hydrogel with self-healing properties, its preparation method and its application in myocardial repair |
CN112500585A (en) * | 2020-10-22 | 2021-03-16 | 湖北大学 | CS/TA/PAA-Al3+Composite ionic hydrogel and preparation method and application thereof |
CN112753759A (en) * | 2020-12-30 | 2021-05-07 | 江苏大学 | Preparation method and application of composite fresh-keeping film coating agent for relieving browning of fresh-cut apples |
CN113336969A (en) * | 2021-06-04 | 2021-09-03 | 南通大学 | Injectable self-repairing nano short fiber hydrogel and preparation method and application thereof |
CN113577376A (en) * | 2021-08-10 | 2021-11-02 | 四川大学 | Double-heavy-load drug polysaccharide-based self-healing hydrogel and preparation method thereof |
CN114129766A (en) * | 2021-12-13 | 2022-03-04 | 昆明理工大学 | Preparation method and application of nano-enzyme antibacterial hydrogel |
CN114146215A (en) * | 2021-12-14 | 2022-03-08 | 深圳市世格赛思医疗科技有限公司 | Injectable hydrogel with antibacterial, antioxidant and hemostatic effects and preparation method and application thereof |
CN114272433A (en) * | 2021-12-25 | 2022-04-05 | 陕西科技大学 | A kind of gelatin-based biomedical adhesive and preparation method thereof |
CN114886844A (en) * | 2022-05-31 | 2022-08-12 | 安徽工程大学 | Enzymatic reaction regulation-based chitosan/gamma-polyglutamic acid/tannic acid hydrogel and preparation method and application thereof |
CN114957720A (en) * | 2022-05-30 | 2022-08-30 | 大连理工大学 | Self-crosslinking antioxidant PCA-g-CMCS/OSA Schiff base hydrogel and preparation method thereof |
CN115429931A (en) * | 2022-10-24 | 2022-12-06 | 山东爱基康健康科技有限公司 | Chitosan hydrogel dressing containing exosome and preparation method thereof |
CN115531597A (en) * | 2022-08-26 | 2022-12-30 | 海南医学院第一附属医院 | Injectable modified sodium alginate hydrogel and preparation method and application thereof |
CN115624655A (en) * | 2022-06-17 | 2023-01-20 | 朗肽生物制药股份有限公司 | Chitosan-oxidized sodium alginate hydrogel material and preparation method and application thereof |
CN115634314A (en) * | 2022-10-28 | 2023-01-24 | 广州贝奥吉因生物科技股份有限公司 | Non-supported bone repair gel microsphere and preparation method thereof |
CN116077721A (en) * | 2023-02-20 | 2023-05-09 | 深圳锋顺生物科技有限公司 | Gelatin-metal ion injectable hydrogel and preparation method and application thereof |
CN116251239A (en) * | 2023-03-15 | 2023-06-13 | 领博生物科技(杭州)有限公司 | Hydrogel and biological artificial blood vessel prepared from same |
CN116510066A (en) * | 2023-04-07 | 2023-08-01 | 华南理工大学 | Temperature-sensitive transition point adjustable drug sustained-release carrier hydrogel and preparation method thereof |
CN116549716A (en) * | 2023-04-28 | 2023-08-08 | 福州大学 | Hydrogel dressing with bacteria in-situ detection and photoresponsive antibacterial function, and preparation method and application thereof |
CN117599233A (en) * | 2023-11-17 | 2024-02-27 | 中国人民解放军海军军医大学第一附属医院 | Multifunctional self-gel polysaccharide-based hemostatic powder and preparation method and application thereof |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101463145A (en) * | 2009-01-12 | 2009-06-24 | 武汉理工大学 | Carboxymethyl chitosan / oxidized sodium alginate self-crosslinking antibacterial hydrogel material |
US20110059162A1 (en) * | 2009-09-04 | 2011-03-10 | Jess Dreher Reed | Tannin-chitosan composites |
CN103083713A (en) * | 2012-12-10 | 2013-05-08 | 江苏华亿细胞组织工程有限公司 | Sterile polymerized covering dressing for wound surface |
EP2872118A2 (en) * | 2012-07-13 | 2015-05-20 | International Flavors & Fragrances Inc. | Hydrogel fragrance capsule, formulations and process for preparing the same |
US20150223464A1 (en) * | 2014-02-07 | 2015-08-13 | Gojo Industries, Inc. | Compositions and Methods With Efficacy Against Spores And Other Organisms |
CN105107008A (en) * | 2015-09-16 | 2015-12-02 | 中南民族大学 | Hydroxybutyl chitosan/oxidized sodium alginate/nano-silver composite hydrogel dressing plaster |
CN107321333A (en) * | 2017-08-23 | 2017-11-07 | 齐鲁工业大学 | A kind of preparation method for the hydrogel microsphere for adsorbing dye ions |
US20180021241A1 (en) * | 2015-01-12 | 2018-01-25 | International Flavors & Fragrances Inc. | Hydrogel capsules and process for preparing the same |
CN108310452A (en) * | 2018-04-11 | 2018-07-24 | 南京工业大学 | Temperature-sensitive glucan-based hydrogel and preparation method thereof |
CN108815587A (en) * | 2018-07-05 | 2018-11-16 | 四川大学 | A kind of hydrogel coating and preparation method thereof with long-term antibacterial functions |
CN110314242A (en) * | 2018-11-09 | 2019-10-11 | 上海长征医院 | A kind of preparation method and its usage of the antibiotic composite hydrogel of controlled release |
-
2020
- 2020-01-08 CN CN202010017199.4A patent/CN111150880A/en active Pending
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101463145A (en) * | 2009-01-12 | 2009-06-24 | 武汉理工大学 | Carboxymethyl chitosan / oxidized sodium alginate self-crosslinking antibacterial hydrogel material |
US20110059162A1 (en) * | 2009-09-04 | 2011-03-10 | Jess Dreher Reed | Tannin-chitosan composites |
EP2872118A2 (en) * | 2012-07-13 | 2015-05-20 | International Flavors & Fragrances Inc. | Hydrogel fragrance capsule, formulations and process for preparing the same |
CN103083713A (en) * | 2012-12-10 | 2013-05-08 | 江苏华亿细胞组织工程有限公司 | Sterile polymerized covering dressing for wound surface |
US20150223464A1 (en) * | 2014-02-07 | 2015-08-13 | Gojo Industries, Inc. | Compositions and Methods With Efficacy Against Spores And Other Organisms |
US20180021241A1 (en) * | 2015-01-12 | 2018-01-25 | International Flavors & Fragrances Inc. | Hydrogel capsules and process for preparing the same |
CN105107008A (en) * | 2015-09-16 | 2015-12-02 | 中南民族大学 | Hydroxybutyl chitosan/oxidized sodium alginate/nano-silver composite hydrogel dressing plaster |
CN107321333A (en) * | 2017-08-23 | 2017-11-07 | 齐鲁工业大学 | A kind of preparation method for the hydrogel microsphere for adsorbing dye ions |
CN108310452A (en) * | 2018-04-11 | 2018-07-24 | 南京工业大学 | Temperature-sensitive glucan-based hydrogel and preparation method thereof |
CN108815587A (en) * | 2018-07-05 | 2018-11-16 | 四川大学 | A kind of hydrogel coating and preparation method thereof with long-term antibacterial functions |
CN110314242A (en) * | 2018-11-09 | 2019-10-11 | 上海长征医院 | A kind of preparation method and its usage of the antibiotic composite hydrogel of controlled release |
Non-Patent Citations (4)
Title |
---|
B.KACZMAREK等: "The characterization of thin films based on chitosan and tannic acid mixture for potential applications as wound dressings", 《POLYMER TESTING》 * |
NEETHU NINAN等: "Antibacterial and Anti-Inflammatory pH-Responsive Tannic Acid-Carboxylated Agarose Composite Hydrogels for Wound Healing", 《ACS APPL. MATER. INTERFACES》 * |
刘文著: "《全国中医药行业高等教育"十三五"规划教材 药用高分子材料学》", 31 July 2017, 中国中医药出版社 * |
李云洁等: "软骨组织工程用羧甲基壳聚糖/氧化海藻酸钠复合水凝胶的制备及体外评估", 《华西口腔医学杂志》 * |
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111793224A (en) * | 2020-06-28 | 2020-10-20 | 武汉科技大学 | Preparation method and application of biomimetic fibrous mesh hydrogel with self-healing properties |
CN111793224B (en) * | 2020-06-28 | 2023-05-16 | 武汉科技大学 | Preparation method and application of bionic fiber web hydrogel with self-repairing performance |
CN111905152A (en) * | 2020-07-06 | 2020-11-10 | 中国科学院上海硅酸盐研究所 | Silicon-based bioactive glass composite hydrogel with self-healing properties, its preparation method and its application in myocardial repair |
CN111905152B (en) * | 2020-07-06 | 2022-03-08 | 中国科学院上海硅酸盐研究所 | Silicon-based bioactive glass composite hydrogel with self-healing characteristic, preparation method thereof and application thereof in myocardial repair |
CN112500585A (en) * | 2020-10-22 | 2021-03-16 | 湖北大学 | CS/TA/PAA-Al3+Composite ionic hydrogel and preparation method and application thereof |
CN112753759A (en) * | 2020-12-30 | 2021-05-07 | 江苏大学 | Preparation method and application of composite fresh-keeping film coating agent for relieving browning of fresh-cut apples |
CN113336969A (en) * | 2021-06-04 | 2021-09-03 | 南通大学 | Injectable self-repairing nano short fiber hydrogel and preparation method and application thereof |
CN113336969B (en) * | 2021-06-04 | 2022-03-11 | 南通大学 | An injectable self-healing nano short fiber hydrogel and its preparation method and application |
CN113577376A (en) * | 2021-08-10 | 2021-11-02 | 四川大学 | Double-heavy-load drug polysaccharide-based self-healing hydrogel and preparation method thereof |
CN114129766A (en) * | 2021-12-13 | 2022-03-04 | 昆明理工大学 | Preparation method and application of nano-enzyme antibacterial hydrogel |
CN114146215A (en) * | 2021-12-14 | 2022-03-08 | 深圳市世格赛思医疗科技有限公司 | Injectable hydrogel with antibacterial, antioxidant and hemostatic effects and preparation method and application thereof |
CN114272433A (en) * | 2021-12-25 | 2022-04-05 | 陕西科技大学 | A kind of gelatin-based biomedical adhesive and preparation method thereof |
CN114957720A (en) * | 2022-05-30 | 2022-08-30 | 大连理工大学 | Self-crosslinking antioxidant PCA-g-CMCS/OSA Schiff base hydrogel and preparation method thereof |
CN114957720B (en) * | 2022-05-30 | 2024-09-10 | 大连理工大学 | Self-crosslinking antioxidant PCA-g-CMCS/OSA Schiff base hydrogel and preparation method thereof |
CN114886844A (en) * | 2022-05-31 | 2022-08-12 | 安徽工程大学 | Enzymatic reaction regulation-based chitosan/gamma-polyglutamic acid/tannic acid hydrogel and preparation method and application thereof |
CN114886844B (en) * | 2022-05-31 | 2023-05-23 | 安徽工程大学 | A chitosan/γ-polyglutamic acid/tannic acid hydrogel based on enzymatic reaction regulation and its preparation method and application |
CN115624655A (en) * | 2022-06-17 | 2023-01-20 | 朗肽生物制药股份有限公司 | Chitosan-oxidized sodium alginate hydrogel material and preparation method and application thereof |
CN115624655B (en) * | 2022-06-17 | 2023-10-20 | 朗肽生物制药股份有限公司 | Chitosan-oxidized sodium alginate hydrogel material and preparation method and application thereof |
CN115531597A (en) * | 2022-08-26 | 2022-12-30 | 海南医学院第一附属医院 | Injectable modified sodium alginate hydrogel and preparation method and application thereof |
CN115429931B (en) * | 2022-10-24 | 2023-08-15 | 山东爱基康健康科技有限公司 | Chitosan hydrogel dressing containing exosomes and preparation method thereof |
CN115429931A (en) * | 2022-10-24 | 2022-12-06 | 山东爱基康健康科技有限公司 | Chitosan hydrogel dressing containing exosome and preparation method thereof |
CN115634314A (en) * | 2022-10-28 | 2023-01-24 | 广州贝奥吉因生物科技股份有限公司 | Non-supported bone repair gel microsphere and preparation method thereof |
CN116077721A (en) * | 2023-02-20 | 2023-05-09 | 深圳锋顺生物科技有限公司 | Gelatin-metal ion injectable hydrogel and preparation method and application thereof |
CN116077721B (en) * | 2023-02-20 | 2024-12-03 | 深圳锋顺生物科技有限公司 | Gelatin-metal ion injectable hydrogel and preparation method and application thereof |
CN116251239A (en) * | 2023-03-15 | 2023-06-13 | 领博生物科技(杭州)有限公司 | Hydrogel and biological artificial blood vessel prepared from same |
CN116510066A (en) * | 2023-04-07 | 2023-08-01 | 华南理工大学 | Temperature-sensitive transition point adjustable drug sustained-release carrier hydrogel and preparation method thereof |
CN116549716A (en) * | 2023-04-28 | 2023-08-08 | 福州大学 | Hydrogel dressing with bacteria in-situ detection and photoresponsive antibacterial function, and preparation method and application thereof |
CN117599233A (en) * | 2023-11-17 | 2024-02-27 | 中国人民解放军海军军医大学第一附属医院 | Multifunctional self-gel polysaccharide-based hemostatic powder and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111150880A (en) | Antibacterial composite hydrogel and preparation method thereof | |
Sadeghi et al. | Carboxymethyl cellulose-human hair keratin hydrogel with controlled clindamycin release as antibacterial wound dressing | |
Zheng et al. | Preparation of triamcinolone acetonide-loaded chitosan/fucoidan hydrogel and its potential application as an oral mucosa patch | |
Morgado et al. | Ibuprofen loaded PVA/chitosan membranes: A highly efficient strategy towards an improved skin wound healing | |
Kim et al. | Development of clindamycin-loaded wound dressing with polyvinyl alcohol and sodium alginate | |
Yin et al. | A self-healing hydrogel based on oxidized microcrystalline cellulose and carboxymethyl chitosan as wound dressing material | |
CN111154149A (en) | A kind of hydrogel and its preparation method and dressing | |
JP2004534111A (en) | Bifunctional modified hydrogel | |
CN114524950B (en) | Hydrophobic drug carrier hydrogel and preparation method and application thereof | |
Cao et al. | Photo-crosslinked enhanced double-network hydrogels based on modified gelatin and oxidized sodium alginate for diabetic wound healing | |
Yang et al. | A pH responsive tannic acid/quaternized carboxymethyl chitosan/oxidized sodium alginate hydrogels for accelerated diabetic wound healing and real-time monitoring | |
CN114569784B (en) | Folium artemisiae argyi extract-loaded hydrogel and preparation method thereof | |
Li et al. | Ganoderma lucidum polysaccharide hydrogel accelerates diabetic wound healing by regulating macrophage polarization | |
CN112831065B (en) | A kind of on-demand dissolvable hydrogel dressing and preparation method and application thereof | |
CN111166931A (en) | Methacrylic acid sericin/chitosan quaternary ammonium salt hydrogel and preparation method and application thereof | |
Zhao et al. | Engineering pH responsive carboxyethyl chitosan and oxidized pectin-based hydrogels with self-healing, biodegradable and antibacterial properties for wound healing | |
CN102940903B (en) | Method for preparing medical dressing of polysaccharide cavernous body | |
CN106139238A (en) | A kind of chitosan collagen sponge dressing and preparation method thereof | |
Singh et al. | Exploring bioactive aloe-vera and sterculia gum to develop hydrogel wound dressings by graft-copolymerization | |
Singh et al. | Design of polysaccharide gum based network copolymeric hydrogels for drug delivery and wound dressing applications | |
CN113509591A (en) | Antibacterial cationic injectable hydrogel dressing and preparation method thereof | |
CN118388798A (en) | Multi-response self-healing hydrogel and preparation method and application thereof | |
CN112870429A (en) | Chitosan-based polyelectrolyte composite hemostatic sponge, preparation method and application | |
CN113368037A (en) | Bovine lactoferrin peptide nanoparticle-loaded chitosan temperature-sensitive hydrogel and preparation method and application thereof | |
EP3882279A1 (en) | Genipin-crosslinked pdrn-sacran biopolymer scaffolds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200515 |